Human Health Holdings Limited (HKG:1419)
0.8200
-0.0300 (-3.53%)
Mar 9, 2026, 3:45 PM HKT
Human Health Holdings Balance Sheet
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 474.53 | 439.9 | 489.58 | 641.26 | 270.33 | 145.27 |
Short-Term Investments | - | - | - | - | - | 17.57 |
Cash & Short-Term Investments | 474.53 | 439.9 | 489.58 | 641.26 | 270.33 | 162.83 |
Cash Growth | -1.11% | -10.15% | -23.65% | 137.21% | 66.02% | 18.70% |
Accounts Receivable | 60.85 | 62.45 | 43.7 | 101.63 | 422.34 | 233.49 |
Other Receivables | - | 20.11 | 23.3 | 2.11 | - | 0.69 |
Receivables | 72.5 | 94 | 67 | 103.74 | 422.34 | 234.18 |
Inventory | 21.91 | 25.08 | 32.28 | 28.33 | 18.33 | 13.96 |
Prepaid Expenses | 38.73 | 27.64 | 23.73 | 22.66 | 18.89 | 2.85 |
Other Current Assets | 1.03 | 1.03 | 1.02 | 1.01 | 2.05 | 2.05 |
Total Current Assets | 608.71 | 587.65 | 613.61 | 796.99 | 731.93 | 415.87 |
Property, Plant & Equipment | 208.34 | 222.37 | 206.42 | 221.86 | 224.38 | 65.34 |
Long-Term Investments | 123.27 | 129.03 | 117.06 | 106.6 | 95.59 | 69.84 |
Goodwill | 54.65 | 54.65 | 31.96 | 31.96 | 31.96 | 31.96 |
Other Intangible Assets | 25.27 | 25.86 | 2.16 | 3.77 | 5.38 | 6.99 |
Long-Term Deferred Tax Assets | 6.54 | 6.34 | 2.84 | 2.41 | 4.94 | 3.97 |
Other Long-Term Assets | 26.47 | 46.07 | 71.08 | 88.55 | 64.44 | 18.41 |
Total Assets | 1,053 | 1,072 | 1,056 | 1,263 | 1,159 | 612.39 |
Accounts Payable | 58.01 | 68.51 | 49.79 | 55.1 | 38.58 | 28.45 |
Accrued Expenses | 2.68 | 22.65 | 26.58 | 40.3 | 41.7 | 37.96 |
Short-Term Debt | 16.09 | 16.83 | 31.54 | 36.51 | 42.22 | 11.66 |
Current Portion of Leases | 49.75 | 49.01 | 49.02 | 48.13 | 39.25 | 41.76 |
Current Income Taxes Payable | 4.93 | 3.02 | 10.69 | 98.63 | 96.18 | 30.39 |
Current Unearned Revenue | 15.14 | 17.15 | 20.77 | 29.11 | 5.72 | 7.4 |
Other Current Liabilities | 47.4 | 26.56 | 27.44 | 41.41 | 37.46 | 27.71 |
Total Current Liabilities | 194 | 203.72 | 215.82 | 349.18 | 301.09 | 185.32 |
Long-Term Leases | 54.19 | 68.71 | 65.9 | 97.85 | 107.01 | 13.66 |
Long-Term Deferred Tax Liabilities | 5.5 | 5.33 | 0.43 | 0.62 | 0.89 | 1.34 |
Other Long-Term Liabilities | 13.31 | 12.46 | 7.56 | 7.62 | 7.68 | 1.94 |
Total Liabilities | 266.99 | 290.22 | 289.71 | 455.27 | 416.67 | 202.26 |
Common Stock | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 | 3.8 |
Additional Paid-In Capital | - | 190.22 | 190.22 | 190.22 | 190.22 | 190.22 |
Retained Earnings | - | 567.75 | 552.04 | 588.54 | 519.67 | 189.9 |
Comprehensive Income & Other | 782.46 | 19.99 | 20.61 | 25.66 | 28.26 | 26.21 |
Total Common Equity | 786.26 | 781.75 | 766.67 | 808.22 | 741.95 | 410.13 |
Shareholders' Equity | 786.26 | 781.75 | 766.67 | 808.22 | 741.95 | 410.13 |
Total Liabilities & Equity | 1,053 | 1,072 | 1,056 | 1,263 | 1,159 | 612.39 |
Total Debt | 120.03 | 134.54 | 146.46 | 182.49 | 188.47 | 67.08 |
Net Cash (Debt) | 354.5 | 305.36 | 343.12 | 458.77 | 81.86 | 95.76 |
Net Cash Growth | 1.96% | -11.00% | -25.21% | 460.41% | -14.51% | 173.45% |
Net Cash Per Share | 0.93 | 0.80 | 0.90 | 1.21 | 0.22 | 0.25 |
Filing Date Shares Outstanding | 379.55 | 379.55 | 379.55 | 379.55 | 379.55 | 379.55 |
Total Common Shares Outstanding | 379.55 | 379.55 | 379.55 | 379.55 | 379.55 | 379.55 |
Working Capital | 414.71 | 383.93 | 397.79 | 447.81 | 430.84 | 230.56 |
Book Value Per Share | 2.07 | 2.06 | 2.02 | 2.13 | 1.95 | 1.08 |
Tangible Book Value | 706.34 | 701.24 | 732.55 | 772.49 | 704.6 | 371.18 |
Tangible Book Value Per Share | 1.86 | 1.85 | 1.93 | 2.04 | 1.86 | 0.98 |
Buildings | - | 18.79 | 13.29 | 12.32 | 12.32 | - |
Machinery | - | 112.52 | 103.95 | 81.39 | 55.52 | 49.78 |
Leasehold Improvements | - | 83.99 | 77.45 | 75.28 | 35.89 | 31.89 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.